1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Key Market Segmentation
3.7. Robust Quality Control
3.8. Limitations
4. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
6. INTRODUCTION
6.1. Chapter Overview
6.2. Introduction to Fill / Finish Services for Small Molecules
6.2.1. Aseptic Filling
6.2.2. Terminal Sterilization
6.2.3. Blow-Fill-Seal Technology
6.3. Need for Outsourcing Small Molecules-related Operations
6.4. Role of Contract Manufacturers in the Small Molecules Industry
6.5. Key Considerations while selecting a Fill / Finish Service Provider
6.6. Advantages of Outsourcing Fill / Finish Services
6.7. Risks and Challenges of Outsourcing Fill / Finish Operations
6.8. Future Perspectives
7. MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Small Molecules Fill / Finish Service Providers: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters
7.2.4. Analysis by Location of Fill / Finish Facilities
7.2.5. Analysis by Scale of Operation
7.2.6. Analysis by Type of Filling Service Offered
7.2.7. Analysis by Type of Finishing Service Offered
7.2.8. Analysis by Type of Packaging Format Used
7.2.9. Analysis by Type of Finished Dosage Form
7.2.10. Analysis by Degree of Automation
8. COMPANY PROFILES: SERVICE PROVIDERS IN NORTH AMERICA
8.1. Chapter Overview
8.2. Leading Small Molecules Fill / Finish Service Providers based in North America
8.2.1. Alcami
8.2.1.1. Company Overview
8.2.1.2. Small Molecules Fill / Finish Service Portfolio
8.2.1.3. Recent Developments and Future Outlook
8.2.2. Pfizer CentreOne
8.2.2.1. Company Overview
8.2.2.2. Small Molecules Fill / Finish Service Portfolio
8.2.2.3. Recent Developments and Future Outlook
8.2.3. Sharp Services
8.2.3.1. Company Overview
8.2.3.2. Small Molecules Fill / Finish Service Portfolio
8.2.3.3. Recent Developments and Future Outlook
8.3. Other Leading Small Molecules Fill / Finish Service Providers based in North America
8.3.1. Burrard Pharmaceuticals
8.3.1.1. Company Overview
8.3.1.2. Small Molecules Fill / Finish Service Portfolio
8.3.2. Plastikon Healthcare
8.3.2.1. Company Overview
8.3.2.2. Small Molecules Fill / Finish Service Portfolio
9. COMPANY PROFILES: SERVICE PROVIDERS IN EUROPE
9.1. Chapter Overview
9.2. Leading Small Molecules Fill / Finish Service Providers based in Europe
9.2.1. Fresenius Kabi
9.2.1.1. Company Overview
9.2.1.2. Financial Information
9.2.1.3. Small Molecules Fill / Finish Service Portfolio
9.2.1.4. Recent Developments and Future Outlook
9.2.2. GlaxoSmithKline
9.2.2.1. Company Overview
9.2.2.2. Financial Information
9.2.2.3. Small Molecules Fill / Finish Service Portfolio
9.2.2.4. Recent Developments and Future Outlook
9.2.3. Recipharm
9.2.3.1. Company Overview
9.2.3.2. Small Molecules Fill / Finish Service Portfolio
9.2.3.3. Recent Developments and Future Outlook
9.3. Other Leading Small Molecules Fill / Finish Service Providers based in Europe
9.3.1. Curida
9.3.1.1. Company Overview
9.3.1.2. Small Molecules Fill / Finish Service Portfolio
9.3.2. ROMMELAG CMO
9.3.2.1. Company Overview
9.3.2.2. Small Molecules Fill / Finish Service Portfolio
10. COMPANY PROFILES: SERVICE PROVIDERS IN ASIA-PACIFIC
10.1. Chapter Overview
10.2. Leading Small Molecules Fill / Finish Service Providers based in Asia-Pacific
10.2.1. Aurigene Pharmaceutical Services
10.2.1.1. Company Overview
10.2.1.2. Small Molecules Fill / Finish Service Portfolio
10.2.1.3. Recent Developments and Future Outlook
10.2.2. Sypharma
10.2.2.1. Company Overview
10.2.2.2. Small Molecules Fill / Finish Service Portfolio
10.2.2.3. Recent Developments and Future Outlook
10.2.3. WuXi AppTec
10.2.3.1. Company Overview
10.2.3.2. Small Molecules Fill / Finish Service Portfolio
10.2.3.3. Recent Developments and Future Outlook
10.3. Other Small Molecules Fill / Finish Service Providers based in Asia-Pacific
10.3.1. Amanta Healthcare
10.3.1.1. Company Overview
10.3.1.2. Small Molecules Fill / Finish Service Portfolio
11. COMPANY PROFILES: SERVICE PROVIDERS IN REST OF THE WORLD
11.1. Chapter Overview
11.2. Leading Small Molecules Fill / Finish Service Providers based in Rest of the World
11.2.1. Eriochem
11.2.1.1. Company Overview
11.2.1.2. Small Molecules Fill / Finish Service Portfolio
11.2.1.3. Recent Developments and Future Outlook
11.2.2. Teva Pharmaceutical Industries
11.2.2.1. Company Overview
11.2.2.2. Small Molecules Fill / Finish Service Portfolio
11.2.2.3. Recent Developments and Future Outlook
11.3. Other Small Molecules Fill / Finish Service Providers based in Rest of the World
11.3.1. Batterjee Pharma
11.3.1.1. Company Overview
11.3.1.2. Small Molecules Fill / Finish Service Portfolio
11.3.2. Procaps
11.3.2.1. Company Overview
11.3.2.2. Small Molecules Fill / Finish Service Portfolio
12. COMPANY COMPETITIVENESS ANALYSIS
12.1. Chapter Overview
12.2. Assumptions and Key Parameters
12.3. Methodology
12.4. Small Molecules Fill / Finish Service Providers based in North America
12.5. Small Molecules Fill / Finish Service Providers based in Europe
12.6. Small Molecules Fill / Finish Service Providers based in Asia-Pacific and Rest of the World
13. CAPACITY ANALYSIS
13.1. Chapter Overview
13.2. Global Annual Small Molecules Fill / Finish Capacity for Ampoules (Number of Units)
13.2.1. Key Assumptions and Methodology
13.2.2. Analysis by Company Size
13.2.3. Analysis by Geography
13.2.3.1. Analysis of Small Molecules Fill / Finish Capacity for Ampoules in North America
13.2.3.2. Analysis of Small Molecules Fill / Finish Capacity for Ampoules in Europe
13.2.3.3. Analysis of Small Molecules Fill / Finish Capacity for Ampoules in Asia-Pacific and Rest of the World
13.3. Global Annual Small Molecules Fill / Finish Capacity for Cartridges (Number of Units)
13.3.1. Key Assumptions and Methodology
13.3.2. Analysis by Company Size
13.3.3. Analysis by Geography
13.3.3.1. Analysis of Small Molecules Fill / Finish Capacity for Cartridges in North America
13.3.3.2. Analysis of Small Molecules Fill / Finish Capacity for Cartridges in Europe
13.3.3.3. Analysis of Small Molecules Fill / Finish Capacity for Cartridges in Asia-Pacific and Rest of the World
13.4. Global Annual Small Molecules Fill / Finish Capacity for Prefilled Syringes (Number of Units)
13.4.1. Key Assumptions and Methodology
13.4.2. Analysis by Company Size
13.4.3. Analysis by Geography
13.4.3.1. Analysis of Small Molecules Fill / Finish Capacity for Prefilled Syringes in North America
13.4.3.2. Analysis of Small Molecules Fill / Finish Capacity for Prefilled Syringes in Europe
13.4.3.3. Analysis of Small Molecules Fill / Finish Capacity for Prefilled Syringes in Asia-Pacific and Rest of the World
13.5. Global Annual Small Molecules Fill / Finish Capacity for Vials (Number of Units)
13.5.1. Key Assumptions and Methodology
13.5.2. Analysis by Company Size
13.5.3. Analysis by Geography
13.5.3.1. Analysis of Small Molecules Fill / Finish Capacity for Vials in North America
13.5.3.2. Analysis of Small Molecules Fill / Finish Capacity for Vials in Europe
13.5.3.3. Analysis of Small Molecules Fill / Finish Capacity for Vials in Asia-Pacific and Rest of the World
14. CASE STUDY: ROBOTIC SYSTEMS IN FILL / FINISH OPERATIONS
14.1. Chapter Overview
14.2. Role of Robotic Systems in Fill / Finish Operations
14.2.1. Types of Robots Used
14.2.2. Key Considerations for Selecting Robotic Systems
14.3. Companies Providing Robots for use in the Pharmaceutical Industry
14.4. Companies Providing Isolator- based Aseptic Filling Systems
14.5. Small Molecules Fill / Finish Service Providers: List of Equipment Used
14.6. Concluding Remarks
15. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS FOR ASEPTIC FILL / FINISH
15.1. Chapter Overview
15.2. Role of Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations
15.2.1. Advantages of Ready-to-Use Packaging Components
15.2.2. Disadvantages of Ready-to-Use Packaging Components
15.3. Companies Providing Ready-to-Use Packaging Components
15.4. Concluding Remarks
16. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
16.1. Chapter Overview
16.2. Market Drivers
16.3. Market Restraints
16.4. Market Opportunities
16.5. Market Challenges
16.6. Conclusion
17. GLOBAL PHARMACEUTICAL FILL / FINISH MANUFACTURING MARKET
17.1. Chapter Overview
17.2. Assumptions and Methodology
17.3. Global Pharmaceutical Fill / Finish Manufacturing Market, till 2035
17.3.1. Scenario Analysis
17.3.1.1. Conservative Scenario
17.3.1.2. Optimistic Scenario
17.4. Key Market Segmentations
18. PHARMACEUTICAL FILL / FINISH MANUFACTURING MARKET, BY TYPE OF FILL / FINISH SERVICE OFFERED
18.1. Chapter Overview
18.2. Assumptions and Methodology
18.3. Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Type of Fill / Finish Service Offered, 2019, Current Year and 2035
18.3.1. Pharmaceutical Fill / Finish Manufacturing Market for Terminal Sterilization, till 2035
18.3.2. Pharmaceutical Fill / Finish Manufacturing Market for Aseptic Filling, till 2035
18.3.3. Pharmaceutical Fill / Finish Manufacturing Market for Blow-Fill-Seal, till 2035
18.4. Pharmaceutical Fill / Finish Manufacturing Market, by Type of Fill / Finish Services Offered: Market Dynamics Assessment
18.4.1. Penetration-Growth (P-G) Matrix
18.4.2. Data Triangulation and Validation
19. PHARMACEUTICAL FILL / FINISH MANUFACTURING MARKET, BY TYPE OF FDF
19.1. Chapter Overview
19.2. Assumptions and Methodology
19.3. Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Type of FDF, 2019, Current Year and 2035
19.3.1. Pharmaceutical Fill / Finish Manufacturing Market for Generic FDF, till 2035
19.3.2. Pharmaceutical Fill / Finish Manufacturing Market for Originator FDF, till 2035
19.4. Pharmaceutical Fill / Finish Manufacturing Market, by Type of FDF: Market Dynamics Assessment
19.4.1. Penetration-Growth (P-G) Matrix
19.4.2. Data Triangulation and Validation
20. PHARMACEUTICAL FILL / FINISH MANUFACTURING MARKET, BY API POTENCY
20.1. Chapter Overview
20.2. Assumptions and Methodology
20.3. Pharmaceutical Fill / Finish Manufacturing Market: Distribution by API Potency, 2019, Current Year and 2035
20.3.1. Pharmaceutical Fill / Finish Manufacturing Market for Low Potent API, till 2035
20.3.2. Pharmaceutical Fill / Finish Manufacturing Market for High Potent API, till 2035
20.4. Pharmaceutical Fill / Finish Manufacturing Market, by API Potency: Market Dynamics Assessment
20.4.1. Penetration-Growth (P-G) Matrix
20.4.2. Data Triangulation and Validation
21. PHARMACEUTICAL FILL / FINISH MANUFACTURING MARKET, BY TYPE OF PRIMARY PACKAGING CONTAINER
21.1. Chapter Overview
21.2. Assumptions and Methodology
21.3. Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Type of Primary Packaging Container, 2019, Current Year and 2035
21.3.1. Pharmaceutical Fill / Finish Manufacturing Market for Vials, till 2035
21.3.2. Pharmaceutical Fill / Finish Manufacturing Market for Ampoules, till 2035
21.3.3. Pharmaceutical Fill / Finish Manufacturing Market for Prefilled Syringes, till 2035
21.3.4. Pharmaceutical Fill / Finish Manufacturing Market for Cartridges, till 2035
21.3.5. Pharmaceutical Fill / Finish Manufacturing Market for Other Containers, till 2035
21.4. Pharmaceutical Fill / Finish Manufacturing Market, by Type of Primary Packaging Container: Market Dynamics Assessment
21.4.1. Penetration-Growth (P-G) Matrix
21.4.2. Data Triangulation and Validation
22. PHARMACEUTICAL FILL / FINISH MANUFACTURING MARKET, BY SCALE OF OPERATION
22.1. Chapter Overview
22.2. Assumptions and Methodology
22.3. Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Scale of Operation, 2019, Current Year and 2035
22.3.1. Pharmaceutical Fill / Finish Manufacturing Market for Clinical Scale, till 2035
22.3.2. Pharmaceutical Fill / Finish Manufacturing Market for Commercial Scale, till 2035
22.4. Pharmaceutical Fill / Finish Manufacturing Market, by Scale of Operation: Market Dynamics Assessment
22.4.1. Penetration-Growth (P-G) Matrix
22.4.2. Data Triangulation and Validation
23. PHARMACEUTICAL FILL / FINISH MANUFACTURING MARKET, BY COMPANY SIZE
23.1. Chapter Overview
23.2. Assumptions and Methodology
23.3. Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Company Size, 2019, Current Year and 2035
23.3.1. Pharmaceutical Fill / Finish Manufacturing Market for Small and Mid-sized Companies, till 2035
23.3.2. Pharmaceutical Fill / Finish Manufacturing Market for Large / Very Large Companies, till 2035
23.4. Pharmaceutical Fill / Finish Manufacturing Market, by Company Size: Market Dynamics Assessment
23.4.1. Penetration-Growth (P-G) Matrix
23.4.2. Data Triangulation and Validation
24. PHARMACEUTICAL FILL / FINISH MANUFACTURING MARKET, BY GEOGRAPHICAL REGIONS
24.1. Chapter Overview
24.2. Assumptions and Methodology
24.3. Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Geographical Regions, 2019, Current Year and 2035
24.3.1. Pharmaceutical Fill / Finish Manufacturing Market in North America, till 2035
24.3.1.1. Pharmaceutical Fill / Finish Manufacturing Market in the US, till 2035
24.3.1.2. Pharmaceutical Fill / Finish Manufacturing Market in Canada, till 2035
24.3.1.3. Pharmaceutical Fill / Finish Manufacturing Market in Mexico, till 2035
24.3.1.4. Pharmaceutical Fill / Finish Manufacturing Market in Puerto Rico, till 2035
24.3.2. Pharmaceutical Fill / Finish Manufacturing Market in Europe, till 2035
24.3.2.1. Pharmaceutical Fill / Finish Manufacturing Market in France, till 2035
24.3.2.2. Pharmaceutical Fill / Finish Manufacturing Market in Germany, till 2035
24.3.2.3. Pharmaceutical Fill / Finish Manufacturing Market in Italy, till 2035
24.3.2.4. Pharmaceutical Fill / Finish Manufacturing Market in the UK, till 2035
24.3.2.5. Pharmaceutical Fill / Finish Manufacturing Market in Spain, till 2035
24.3.2.6. Pharmaceutical Fill / Finish Manufacturing Market in Rest of Europe, till 2035
24.3.3. Pharmaceutical Fill / Finish Manufacturing Market in Asia-Pacific, till 2035
24.3.3.1. Pharmaceutical Fill / Finish Manufacturing Market in India, till 2035
24.3.3.2. Pharmaceutical Fill / Finish Manufacturing Market in Japan, till 2035
24.3.3.3. Pharmaceutical Fill / Finish Manufacturing Market in China, till 2035
24.3.3.4. Pharmaceutical Fill / Finish Manufacturing Market in Rest of Asia-Pacific, till 2035
24.3.4. Pharmaceutical Fill / Finish Manufacturing Market in Middle East and North Africa, till 2035
24.3.5. Pharmaceutical Fill / Finish Manufacturing Market in Latin America, till 2035
24.3.6. Pharmaceutical Fill / Finish Manufacturing Market in Rest of the World, till 2035
24.4. Pharmaceutical Fill / Finish Manufacturing Market, by Geographical Regions: Market Dynamics Assessment
24.4.1. Penetration-Growth (P-G) Matrix
24.4.2. Data Triangulation and Validation
25. PHARMACEUTICAL FILL / FINISH MANUFACTURING MARKET, BY LEADING PLAYERS
25.1. Chapter Overview
25.2. Leading Industry Players
27. EXECUTIVE INSIGHT
27.1. Chapter Overview
27.2. Company A
27.2.1. Company Snapshot
27.2.2. Interview Transcript: Senior Executive Director, Global Sales and Marketing
List of Tables
Table 7.1 Small Molecules Fill / Finish Service Providers: List of Companies
Table 7.2 Small Molecules Fill / Finish Service Providers: Information on Scale of Operation, Type of Filling Service Offered and Type of Finishing Service Offered
Table 7.3 Small Molecules Fill / Finish Service Providers: Information on Type of Packaging Format Used, Type of Finished Dosage Form and Degree of Automation
Table 8.1 Small Molecules Fill / Finish Service Providers in North America: List of Companies Profiled
Table 8.2 Alcami: Company Overview
Table 8.3 Alcami: Small Molecules Fill / Finish Service Portfolio
Table 8.4 Alcami: Recent Developments and Future Outlook
Table 8.5 Pfizer CentreOne: Company Overview
Table 8.6 Pfizer CentreOne: Small Molecules Fill / Finish Service Portfolio
Table 8.7 Sharp Services: Company Overview
Table 8.8 Sharp Services: Small Molecules Fill / Finish Service Portfolio
Table 8.9 Sharp Services: Recent Developments and Future Outlook
Table 8.10 Burrard Pharmaceuticals: Company Overview
Table 8.11 Burrard Pharmaceuticals: Small Molecules Fill / Finish Service Portfolio
Table 8.12 Plastikon Healthcare: Company Overview
Table 8.13 Plastikon Healthcare: Small Molecules Fill / Finish Service Portfolio
Table 9.1 Small Molecules Fill / Finish Service Providers: List of Companies Profiled
Table 9.2 Fresenius Kabi: Company Overview
Table 9.3 Fresenius Kabi: Small Molecules Fill / Finish Service Portfolio
Table 9.4 Fresenius Kabi: Recent Developments and Future Outlook
Table 9.5 GlaxoSmithKline: Company Overview
Table 9.6 GlaxoSmithKline: Small Molecules Fill / Finish Service Portfolio
Table 9.7 GlaxoSmithKline: Recent Developments and Future Outlook
Table 9.8 Recipharm: Company Overview
Table 9.9 Recipharm: Small Molecules Fill / Finish Service Portfolio
Table 9.10 Recipharm: Recent Developments and Future Outlook
Table 9.11 Curida: Company Overview
Table 9.12 Curida: Small Molecules Fill / Finish Service Portfolio
Table 9.13 ROMMELAG CMO: Company Overview
Table 9.14 ROMMELAG CMO: Small Molecules Fill / Finish Service Portfolio
Table 10.1 Small Molecules Fill / Finish Service Providers: List of Companies Profiled
Table 10.2 Aurigene Pharmaceutical Services: Company Overview
Table 10.3 Aurigene Pharmaceutical Services: Small Molecules Fill / Finish Service Portfolio
Table 10.4 Aurigene Pharmaceutical Services: Recent Developments and Future Outlook
Table 10.5 Sypharma: Company Overview
Table 10.6 Sypharma: Small Molecules Fill / Finish Service Portfolio
Table 10.7 Sypharma: Recent Developments and Future Outlook
Table 10.8 WuXi AppTec: Company Overview
Table 10.9 WuXi AppTec: Small Molecules Fill / Finish Service Portfolio
Table 10.10 WuXi AppTec: Recent Developments and Future Outlook
Table 10.11 Amanta Healthcare: Company Overview
Table 10.12 Amanta Healthcare: Small Molecules Fill / Finish Service Portfolio
Table 11.1 Small Molecules Fill / Finish Service Providers: List of Companies Profiled
Table 11.2 Eriochem: Company Overview
Table 11.3 Eriochem: Small Molecules Fill / Finish Service Portfolio
Table 11.4 Teva Pharmaceutical Industries: Company Overview
Table 11.5 Teva Pharmaceutical Industries: Small Molecules Fill / Finish Service Portfolio
Table 11.6 Teva Pharmaceutical Industries: Recent Developments and Future Outlook
Table 11.7 Batterjee Pharma: Company Overview
Table 11.8 Batterjee Pharma: Small Molecules Fill / Finish Service Portfolio
Table 11.9 Nextar Chempharma Solutions: Company Overview
Table 11.10 Nextar Chempharma Solutions: Small Molecules Fill / Finish Service Portfolio
Table 11.11 Procaps: Company Overview
Table 11.12 Procaps: Small Molecules Fill / Finish Service Portfolio
Table 13.1 Small Molecules Fill / Finish Service Providers: Information on Total Capacity for Ampoules (Sample Data Set)
Table 13.2 Small Molecules Fill / Finish Service Providers: Average Capacity per Facility for Ampoules, by Company Size (Sample Dataset)
Table 13.3 Global Annual Small Molecules Fill / Finish Capacity for Ampoules, by Company Size (in terms of units)
Table 13.4 Small Molecules Fill / Finish Service Providers: Information on Total Capacity for Cartridges (Sample Data Set)
Table 13.5 Small Molecules Fill / Finish Service Providers: Average Capacity per Facility for Cartridges, by Company Size (Sample Dataset)
Table 13.6 Global Annual Small Molecules Fill / Finish Capacity for Cartridges, by Company Size (in terms of units)
Table 13.7 Small Molecules Fill / Finish Service Providers: Information on Total Capacity for Prefilled Syringes (Sample Data Set)
Table 13.8 Small Molecules Fill / Finish Service Providers: Average Capacity per Facility for Prefilled Syringes, by Company Size (Sample Dataset)
Table 13.9 Global Annual Small Molecules Fill / Finish Capacity for Prefilled Syringes, by Company Size (in terms of units)
Table 13.10 Small Molecules Fill / Finish Service Providers: Information on Total Capacity for Vials (Sample Data Set)
Table 13.11 Small Molecules Fill / Finish Service Providers: Average Capacity for Vials, by Company Size (Sample Dataset)
Table 13.12 Global Annual Small Molecules Fill / Finish Capacity for Vials: Total Capacity by Company Size (in terms of units)
Table 14.1 List of Companies Providing Robots for Use in Pharmaceutical Industry
Table 14.2 Isolator-based Aseptic Filling Systems: Information on Compatible Primary Container
Table 14.3 Small Molecules Fill / Finish Service Providers: Information on Fill / Finish Equipment Used
Table 15.1 List of Companies Providing Ready-to-Use Packaging Components
Table 25.1 Leading Industry Players: Based on the Annual Capacity Installed
Table 27.1 Bushu Pharmaceuticals: Company Overview
Table 28.1 Small Molecules Fill / Finish Service Providers: Distribution by Year of Establishment
Table 28.2 Small Molecules Fill / Finish Service Providers: Distribution by Company Size
Table 28.3 Small Molecules Fill / Finish Service Providers: Distribution by Location of Headquarters
Table 28.4 Small Molecules Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Table 28.5 Small Molecules Fill / Finish Service Providers: Distribution by Scale of Operation
Table 28.6 Small Molecules Fill / Finish Service Providers: Distribution by Type of Filling Service Offered
Table 28.7 Small Molecules Fill / Finish Service Providers: Distribution by Type of Finishing Service Offered
Table 28.8 Small Molecules Fill / Finish Service Providers: Distribution by Type of Packaging Format Used
Table 28.9 Small Molecules Fill / Finish Service Providers: Distribution by Type of Finished Dosage Form
Table 28.10 Small Molecules Fill / Finish Service Providers: Distribution by Degree of Automation
Table 28.11 Pfizer (parent company of Pfizer CentreOne): Business Segment-wise Revenues and Consolidated Financial Details (USD Billion)
Table 28.12 Fresenius Kabi: Business Segment-wise Revenues and Consolidated Financial Details (EUR Billion)
Table 28.13 GlaxoSmithKline: Business Segment-wise Revenues and Consolidated Financial Details (EUR Billion)
Table 28.14 WuXi AppTec: Business Segment-wise Revenues and Consolidated Financial Details (RMB Billion)
Table 28.15 Global Annual Small Molecules Fill / Finish Capacity for Ampoules: Distribution by Company Size
Table 28.16 Global Annual Small Molecules Fill / Finish Capacity for Ampoules: Distribution by Location of Fill / Finish Facility
Table 28.17 Small Molecules Fill / Finish Capacity for Ampoules in North America
Table 28.18 Small Molecules Fill / Finish Capacity for Ampoules in Europe
Table 28.19 Small Molecules Fill / Finish Capacity for Ampoules in Asia-Pacific and Rest of the World
Table 28.20 Global Annual Small Molecules Fill / Finish Capacity for Cartridges: Distribution by Company Size
Table 28.21 Global Annual Small Molecules Fill / Finish Capacity for Cartridges: Distribution by Location of Fill / Finish Facility
Table 28.22 Small Molecules Fill / Finish Capacity for Cartridges in North America
Table 28.23 Small Molecules Fill / Finish Capacity for Cartridges in Europe
Table 28.24 Small Molecules Fill / Finish Capacity for Cartridges in Asia-Pacific and Rest of the World
Table 28.25 Global Annual Small Molecules Fill / Finish Capacity for Prefilled Syringes: Distribution by Company Size
Table 28.26 Global Annual Small Molecules Fill / Finish Capacity for Prefilled Syringes: Distribution by Location of Fill / Finish Facility
Table 28.27 Small Molecules Fill / Finish Capacity for Prefilled Syringes in North America
Table 28.28 Small Molecules Fill / Finish Capacity for Prefilled Syringes in Europe
Table 28.29 Small Molecules Fill / Finish Capacity for Prefilled Syringes in Asia-Pacific and Rest of the World
Table 28.30 Global Annual Small Molecules Fill / Finish Capacity for Vials: Distribution by Company Size
Table 28.31 Global Annual Small Molecules Fill / Finish Capacity for Vials: Distribution by Location of Fill / Finish Facility
Table 28.32 Small Molecules Fill / Finish Capacity for Vials in North America
Table 28.33 Small Molecules Fill / Finish Capacity for Vials in Europe
Table 28.34 Small Molecules Fill / Finish Capacity for Vials in Asia-Pacific and Rest of the World
Table 28.35 Global Pharmaceutical Fill / Finish Manufacturing Market: Conservative, Base, Optimistic Scenario, till 2035 (USD Billion)
Table 28.36 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Type of Fill / Finish Service Offered, 2019, Current Year and 2035 (USD Billion)
Table 28.37 Pharmaceutical Fill / Finish Manufacturing Market for Terminal Sterilization, till 2035 (USD Billion)
Table 28.38 Pharmaceutical Fill / Finish Manufacturing Market for Aseptic Filling, till 2035 (USD Billion)
Table 25.39 Pharmaceutical Fill / Finish Manufacturing Market for Blow-Fill-Seal, till 2035 (USD Billion)
Table 28.40 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Type of FDF, 2019, Current Year and 2035 (USD Billion)
Table 28.41 Pharmaceutical Fill / Finish Manufacturing Market for Originator FDF, till 2035 (USD Billion)
Table 28.42 Pharmaceutical Fill / Finish Manufacturing Market for Generic FDF, till 2035 (USD Billion)
Table 28.43 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by API Potency, 2019, Current Year and 2035 (USD Billion)
Table 28.44 Pharmaceutical Fill / Finish Manufacturing Market for Low Potent API, till 2035 (USD Billion)
Table 28.45 Pharmaceutical Fill / Finish Manufacturing Market for High Potent API, till 2035 (USD Billion)
Table 28.46 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Type of Primary Packaging Container, 2019, Current Year and 2035 (USD Billion)
Table 28.47 Pharmaceutical Fill / Finish Manufacturing Market for Vials, till 2035 (USD Billion)
Table 28.48 Pharmaceutical Fill / Finish Manufacturing Market for Prefilled Syringes, till 2035 (USD Billion)
Table 28.49 Pharmaceutical Fill / Finish Manufacturing Market for Ampoules, till 2035 (USD Billion)
Table 28.50 Pharmaceutical Fill / Finish Manufacturing Market for Cartridges, till 2035 (USD Billion)
Table 28.51 Pharmaceutical Fill / Finish Manufacturing Market for Other Containers, till 2035 (USD Billion)
Table 28.52 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Scale of Operation, 2019, Current Year and 2035 (USD Billion)
Table 28.53 Pharmaceutical Fill / Finish Manufacturing Market for Clinical Scale, till 2035 (USD Billion)
Table 28.54 Pharmaceutical Fill / Finish Manufacturing Market for Commercial Scale, till 2035 (USD Billion)
Table 28.55 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Company Size, 2019, Current Year and 2035 (USD Billion)
Table 28.56 Pharmaceutical Fill / Finish Manufacturing Market for Small and Mid-sized Companies, till 2035 (USD Billion)
Table 28.57 Pharmaceutical Fill / Finish Manufacturing Market for Large / Very Large Companies, till 2035 (USD Billion)
Table 28.58 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Geographical Regions 2019, Current Year and 2035 (USD Billion)
Table 28.59 Pharmaceutical Fill / Finish Manufacturing Market in North America, till 2035 (USD Billion)
Table 28.60 Pharmaceutical Fill / Finish Manufacturing Market in the US, till 2035 (USD Billion)
Table 28.61 Pharmaceutical Fill / Finish Manufacturing Market in Canada, till 2035 (USD Billion)
Table 28.62 Pharmaceutical Fill / Finish Manufacturing Market in Mexico, till 2035 (USD Billion)
Table 28.63 Pharmaceutical Fill / Finish Manufacturing Market in Puerto Rico, till 2035 (USD Billion)
Table 28.64 Pharmaceutical Fill / Finish Manufacturing Market in Europe, till 2035 (USD Billion)
Table 28.65 Pharmaceutical Fill / Finish Manufacturing Market in France, till 2035 (USD Billion)
Table 28.66 Pharmaceutical Fill / Finish Manufacturing Market in Germany, till 2035 (USD Billion)
Table 28.67 Pharmaceutical Fill / Finish Manufacturing Market in Italy, till 2035 (USD Billion)
Table 28.68 Pharmaceutical Fill / Finish Manufacturing Market in the UK, till 2035 (USD Billion)
Table 28.69 Pharmaceutical Fill / Finish Manufacturing Market in Spain, till 2035 (USD Billion)
Table 28.70 Pharmaceutical Fill / Finish Manufacturing Market in Rest of Europe, till 2035 (USD Billion)
Table 28.71 Pharmaceutical Fill / Finish Manufacturing Market in Asia-Pacific, till 2035 (USD Billion)
Table 28.72 Pharmaceutical Fill / Finish Manufacturing Market in India, till 2035 (USD Billion)
Table 28.73 Pharmaceutical Fill / Finish Manufacturing Market in Japan, till 2035 (USD Billion)
Table 28.74 Pharmaceutical Fill / Finish Manufacturing Market in China, till 2035 (USD Billion)
Table 28.75 Pharmaceutical Fill / Finish Manufacturing Market in Rest of Asia-Pacific, till 2035 (USD Billion)
Table 28.76 Pharmaceutical Fill / Finish Manufacturing Market in Middle East and North Africa, till 2035 (USD Billion)
Table 28.77 Pharmaceutical Fill / Finish Manufacturing Market in Latin America, till 2035 (USD Billion)
Table 28.78 Pharmaceutical Fill / Finish Manufacturing Market in Rest of the World, till 2035 (USD Billion)
List of Figures
Figure 2.1 Research Methodology: Project Methodology
Figure 2.2 Research Methodology: Data Sources for Secondary Research
Figure 3.1 Market Dynamics: Forecast Methodology
Figure 3.2 Market Dynamics: Key Market Segmentation
Figure 3.3 Market Dynamics: Robust Quality Control
Figure 4.1 Lessons Learnt from Past Recessions
Figure 5.1 Executive Summary: Market Landscape
Figure 5.2 Executive Summary: Market Forecast and Opportunity Analysis
Figure 6.1 Steps involved in Fill / Finish of Small Molecules
Figure 6.2 Blow-Fill-Seal Process
Figure 6.3 Key Considerations for Selecting a CMO Partner
Figure 6.4 Risks and Challenges of Outsourcing Fill / Finish Operations
Figure 7.1 Small Molecules Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 7.2 Small Molecules Fill / Finish Service Providers: Distribution by Company Size
Figure 7.3 Small Molecules Fill / Finish Service Providers: Distribution by Location of Headquarters
Figure 7.4 Small Molecules Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Figure 7.5 Small Molecules Fill / Finish Service Providers: Distribution by Scale of Operation
Figure 7.6 Small Molecules Fill / Finish Service Providers: Distribution by Type of Filling Service Offered
Figure 7.7 Small Molecules Fill / Finish Service Providers: Distribution by Type of Finishing Service Offered
Figure 7.8 Small Molecules Fill / Finish Service Providers: Analysis by Type of Packaging Format Used
Figure 7.9 Small Molecules Fill / Finish Service Providers: Distribution by Type of Finished Dosage Form
Figure 7.10 Small Molecules Fill / Finish Service Providers: Distribution by Degree of Automation
Figure 8.1 Pfizer (parent company of Pfizer CentreOne): Business Segment-wise Revenues and Consolidated Financial Details (USD Billion)
Figure 9.1 Fresenius: Business Segment-wise Revenues and Consolidated Financial Details (EUR Billion)
Figure 9.2 GlaxoSmithKline: Business Segment-wise Revenues and Consolidated Financial Details (EUR Billion)
Figure 10.1 WuXi AppTec: Business Segment-wise Revenues and Consolidated Financial Details (RMB Billion)
Figure 12.1 Company Competitiveness Analysis: Small Molecules Fill / Finish Service Providers based in North America
Figure 12.2 Company Competitiveness Analysis: Small Molecules Fill / Finish Service Providers based in Europe
Figure 12.3 Company Competitiveness Analysis: Small Molecules Fill / Finish Service Providers based in Asia-Pacific and Rest of the World
Figure 13.1 Global Annual Small Molecules Fill / Finish Capacity for Ampoules: Distribution by Company Size
Figure 13.2 Global Annual Small Molecules Fill / Finish Capacity for Ampoules: Distribution by Location of Fill / Finish Facility
Figure 13.3 Small Molecules Fill / Finish Capacity for Ampoules in North America
Figure 13.4 Small Molecules Fill / Finish Capacity for Ampoules in Europe
Figure 13.5 Small Molecules Fill / Finish Capacity for Ampoules in Asia-Pacific and Rest of the World
Figure 13.6 Global Annual Small Molecules Fill / Finish Capacity for Cartridges: Distribution by Company Size
Figure 13.7 Global Annual Small Molecules Fill / Finish Capacity for Cartridges: Distribution by Location of Fill / Finish Facility
Figure 13.8 Small Molecules Fill / Finish Capacity for Cartridges in North America
Figure 13.9 Small Molecules Fill / Finish Capacity for Cartridges in Europe
Figure 13.10 Small Molecules Fill / Finish Capacity for Cartridges in Asia-Pacific and Rest of the World
Figure 13.11 Global Annual Small Molecules Fill / Finish Capacity for Prefilled Syringes: Distribution by Company Size
Figure 13.12 Global Annual Small Molecules Fill / Finish Capacity for Prefilled Syringes: Distribution by Location of Fill / Finish Facility
Figure 13.13 Small Molecules Fill / Finish Capacity for Prefilled Syringes in North America
Figure 13.14 Small Molecules Fill / Finish Capacity for Prefilled Syringes in Europe
Figure 13.15 Small Molecules Fill / Finish Capacity for Prefilled Syringes in Asia-Pacific and Rest of the World
Figure 13.16 Global Annual Small Molecules Fill / Finish Capacity for Vials: Distribution by Company Size
Figure 13.17 Global Annual Small Molecules Fill / Finish Capacity for Vials: Distribution by Location of Fill / Finish Facility
Figure 13.18 Small Molecules Fill / Finish Capacity for Vials in North America
Figure 13.19 Small Molecules Fill / Finish Capacity for Vials in Europe
Figure 13.20 Small Molecules Fill / Finish Capacity for Vials in Asia-Pacific and Rest of the World
Figure 14.1 Key Considerations for Selecting a Robotic Systems
Figure 14.2 Advantages of Using Robotic Systems
Figure 15.1 Key Drivers of Ready-to- Use Components
Figure 16.1 Pharmaceutical Fill / Finish Manufacturing: Market Drivers
Figure 16.2 Pharmaceutical Fill / Finish Manufacturing: Market Restraints
Figure 16.3 Pharmaceutical Fill / Finish Manufacturing: Market Opportunities
Figure 16.4 Pharmaceutical Fill / Finish Manufacturing: Market Challenges
Figure 17.1 Global Pharmaceutical Fill / Finish Manufacturing Market, till 2035 (USD Billion)
Figure 17.2 Global Pharmaceutical Fill / Finish Manufacturing Market, till 2035: Conservative Scenario (USD Billion)
Figure 17.3 Global Pharmaceutical Fill / Finish Manufacturing Market, till 2035: Optimistic Scenario (USD Billion)
Figure 18.1 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Type of Fill / Finish Service Offered, 2019, Current Year and 2035
Figure 18.2 Pharmaceutical Fill / Finish Manufacturing Market for Terminal Sterilization, till 2035 (USD Billion)
Figure 18.3 Pharmaceutical Fill / Finish Manufacturing Market for Aseptic Filling, till 2035 (USD Billion)
Figure 18.4 Pharmaceutical Fill / Finish Manufacturing Market for Blow-Fill-Seal, till 2035 (USD Billion)
Figure 18.5 Penetration-Growth (P-G) Matrix: Type of Fill / Finish Service Offered
Figure 19.1 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Type of FDF, 2019, Current Year and 2035
Figure 19.2 Pharmaceutical Fill / Finish Manufacturing Market for Generic FDF, till 2035 (USD Billion)
Figure 19.3 Pharmaceutical Fill / Finish Manufacturing Market for Originator FDF, till 2035 (USD Billion)
Figure 19.4 Penetration-Growth (P-G) Matrix: Type of FDF
Figure 20.1 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by API Potency, 2019, Current Year and 2035
Figure 20.2 Pharmaceutical Fill / Finish Manufacturing Market for Low Potent API, till 2035 (USD Billion)
Figure 20.3 Pharmaceutical Fill / Finish Manufacturing Market for High Potent API, till 2035 (USD Billion)
Figure 20.4 Penetration-Growth (P-G) Matrix: API Potency
Figure 21.1 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Type of Primary Packaging Container, 2019, Current Year and 2035
Figure 21.2 Pharmaceutical Fill / Finish Manufacturing Market for Vials, till 2035 (USD Billion)
Figure 21.3 Pharmaceutical Fill / Finish Manufacturing Market for Prefilled Syringes, till 2035 (USD Billion)
Figure 21.4 Pharmaceutical Fill / Finish Manufacturing Market for Ampoules, till 2035 (USD Billion)
Figure 21.5 Pharmaceutical Fill / Finish Manufacturing Market for Cartridges, till 2035 (USD Billion)
Figure 21.6 Pharmaceutical Fill / Finish Manufacturing Market for Other Containers, till 2035 (USD Billion)
Figure 21.7 Penetration-Growth (P-G) Matrix: Type of Primary Packaging Container
Figure 22.1 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Scale of Operation, 2019, Current Year and 2035
Figure 22.2 Pharmaceutical Fill / Finish Manufacturing Market for Clinical Scale, till 2035 (USD Billion)
Figure 22.3 Pharmaceutical Fill / Finish Manufacturing Market for Commercial Scale, till 2035 (USD Billion)
Figure 22.4 Penetration-Growth (P-G) Matrix: Scale of Operation
Figure 23.1 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Company Size, 2019, Current Year and 2035
Figure 23.2 Pharmaceutical Fill / Finish Manufacturing Market for Small and Mid-sized Companies, till 2035 (USD Billion)
Figure 23.3 Pharmaceutical Fill / Finish Manufacturing Market for Large / Very Large Companies, till 2035 (USD Billion)
Figure 23.4 Penetration-Growth (P-G) Matrix: Company Size
Figure 24.1 Pharmaceutical Fill / Finish Manufacturing Market: Distribution by Geographical Regions 2019, Current Year and 2035
Figure 24.2 Pharmaceutical Fill / Finish Manufacturing Market in North America, till 2035 (USD Billion)
Figure 24.3 Pharmaceutical Fill / Finish Manufacturing Market in the US, till 2035 (USD Billion)
Figure 24.4 Pharmaceutical Fill / Finish Manufacturing Market in Canada, till 2035 (USD Billion)
Figure 24.5 Pharmaceutical Fill / Finish Manufacturing Market in Mexico, till 2035 (USD Billion)
Figure 24.6 Pharmaceutical Fill / Finish Manufacturing Market in Puerto Rico, till 2035 (USD Billion)
Figure 24.7 Pharmaceutical Fill / Finish Manufacturing Market in Europe, till 2035 (USD Billion)
Figure 24.8 Pharmaceutical Fill / Finish Manufacturing Market in France, till 2035 (USD Billion)
Figure 24.9 Pharmaceutical Fill / Finish Manufacturing Market in Germany, till 2035 (USD Billion)
Figure 24.10 Pharmaceutical Fill / Finish Manufacturing Market in Italy, till 2035 (USD Billion)
Figure 24.11 Pharmaceutical Fill / Finish Manufacturing Market in the UK, till 2035 (USD Billion)
Figure 24.12 Pharmaceutical Fill / Finish Manufacturing Market in Spain, till 2035 (USD Billion)
Figure 24.13 Pharmaceutical Fill / Finish Manufacturing Market in Rest of Europe, till 2035 (USD Billion)
Figure 24.14 Pharmaceutical Fill / Finish Manufacturing Market in Asia-Pacific, till 2035 (USD Billion)
Figure 24.15 Pharmaceutical Fill / Finish Manufacturing Market in India, till 2035 (USD Billion)
Figure 24.16 Pharmaceutical Fill / Finish Manufacturing Market in Japan, till 2035 (USD Billion)
Figure 24.17 Pharmaceutical Fill / Finish Manufacturing Market in China, till 2035 (USD Billion)
Figure 24.18 Pharmaceutical Fill / Finish Manufacturing Market in Rest of Asia-Pacific, till 2035 (USD Billion)
Figure 24.19 Pharmaceutical Fill / Finish Manufacturing Market in Middle East and North Africa, till 2035 (USD Billion)
Figure 24.20 Pharmaceutical Fill / Finish Manufacturing Market in Latin America, till 2035 (USD Billion)
Figure 24.21 Pharmaceutical Fill / Finish Manufacturing Market in Rest of the World, till 2035 (USD Billion)
Figure 24.22 Penetration-Growth (P-G) Matrix: Geographical Regions
Figure 26.1 Conclusion: Small Molecules Fill / Finish Service Providers Landscape
Figure 26.2 Conclusion: Capacity Analysis
Figure 26.3 Conclusion: Market Forecast and Opportunity Analysis (I/II)
Figure 26.4 Conclusion: Market Forecast and Opportunity Analysis (II/II)
